FHIR © HL7.org  |  Server Home  |  XIG Home  |  XIG Stats  |  Server Source  |  FHIR  

FHIR IG Statistics: FHIR Resources

ValueSets, Realm US

12,841 resources

Source: Text:

By Version

By Authority

  • none: 1,981
  • hl7: 10,860

 

Start Prev Rows 800 - 1000 Next

PackageVersionIdentityName/TitleStatusFMMWGDateAuthSource(s)
us.nlm.vsacR42.16.840.1.113762.1.4.1078.440relatedconditions_T2DM SCTactive2023-09hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1078.442Blood Glucoseactive2024-07hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1078.459Liver canceractive2023-07hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1078.47ACE inhibitor allergy SCTactive2022-08hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1078.474Allergy to Tdap Vaccineactive2023-06hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1078.475Allergy to Td Vaccineactive2023-06hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1078.481medications_hypertensionactive2024-12hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1078.492Inhaled Corticosteroids Allergyactive2023-07hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1078.498Metformin AllergyIntolerance SCTactive2023-09hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1078.508Abdominal aortic imaging CPTactive2023-07hl7cpt
us.nlm.vsacR42.16.840.1.113762.1.4.1078.517Hemoglobin A1cactive2024-03hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1078.518Drug hypersensitivity I10active2023-07hl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1078.519Drug hypersensitivity SCTactive2023-07hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1078.520Drug hypersensitivityactive2023-07hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1078.521Diabetic Kidney Disease I10active2023-07hl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1078.523Diabetic kidney diseaseactive2023-07hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1078.524Chronic Hepatitis SCTactive2023-07hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1078.525Chronic Hepatitisactive2023-07hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1078.527OCS_Prednisoneactive2024-12hl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1078.531Anti IgE Medicationsactive2023-07hl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1078.532IL5 Antagonistsactive2023-07hl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1078.533Mast cell stabilizers for asthmaactive2023-07hl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1078.534Vasospastic disease I10active2023-08hl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1078.535Vasospastic disease SCTactive2023-07hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1078.536Vasospastic diseaseactive2023-07hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1078.537Hemiplegic and basilar migraine I10active2023-07hl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1078.538Hemiplegic and basilar migraine SCTactive2023-07hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1078.539Hemiplegic and basilar migraineactive2023-07hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1078.540Peptic ulcer disease I10active2023-07hl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1078.541Peptic ulcer disease SCTactive2023-07hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1078.542Peptic ulcer diseaseactive2023-07hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1078.544Bleeding disorder I10active2023-07hl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1078.545Bleeding disorder SCTactive2023-07hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1078.548Electronic cigarettes or Vapingactive2023-07hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1078.549Bleeding disorderactive2023-07hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1078.552Triptansactive2023-08hl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1078.553CGRP receptor antagonistsactive2023-08hl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1078.554Ditansactive2023-08hl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1078.555Ergotsactive2023-08hl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1078.556Migraine specific NSAIDsactive2023-08hl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1078.557OTC migraine analgesicsactive2023-08hl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1078.559medications_migraine_acuteactive2023-11hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1078.560relatedconditions_migraine I10active2023-08hl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1078.561conditions_migraineactive2023-08hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1078.562relatedconditions_migraine SCTactive2023-08hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1078.563relatedconditions_migraineactive2023-08hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1078.564Triptan Allergy Intolerance SCTactive2023-08hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1078.565Triptan Allergy Intoleranceactive2025-04hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1078.566Ischemic bowel disease SCTactive2023-08hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1078.567Ischemic bowel disease I10active2023-08hl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1078.568Ischemic bowel diseaseactive2023-08hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1078.573conditions_hyperlipidemia I10active2023-08hl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1078.574conditions_hyperlipidemia SCTactive2023-08hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1078.575conditions_hyperlipidemiaactive2023-08hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1078.578PIM_Schedule Vactive2023-08hl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1078.580PIM_Acarboseactive2023-09hl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1078.582PIM_Dulaglutideactive2023-09hl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1078.583PIM_Glimepirideactive2023-09hl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1078.585PIM_Glucophageactive2023-08hl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1078.587PIM_Glucovanceactive2023-08hl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1078.588Glyburide PIMactive2023-08hl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1078.590Alpha glucosidase inhibitorsactive2023-08hl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1078.592Azotemiaactive2023-08hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1078.594Intolerance to ARB SCTactive2023-09hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1078.595ICS Lowactive2024-12hl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1078.596ICS Mediumactive2023-08hl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1078.597ICS Highactive2023-08hl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1078.598Low Dose ICS Formoterolactive2024-05hl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1078.600PIM_Vitamin B12 Level_LOINCactive2023-09hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1078.601PIM_Vitamin B12 Level_CPTactive2023-09hl7cpt
us.nlm.vsacR42.16.840.1.113762.1.4.1078.604PIM_Glyburideactive2023-09hl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1078.605PIM_Pioglitazoneactive2023-09hl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1078.606PIM_Semaglutideactive2023-09hl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1078.607PIM_Linagliptinactive2023-09hl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1078.609Macrolide_Azithromycinactive2023-08hl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1078.61Secondary antihypertensivesactive2023-07hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1078.610Long Acting Beta Agonists (LABA) Non_Formoterolactive2023-11hl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1078.612Wolff Parkinson White SCTactive2023-09hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1078.613Wolff Parkinson White I10active2023-09hl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1078.614Wolff Parkinson Whiteactive2023-09hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1078.615medications_Asthmaactive2024-12hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1078.619ICS_LABA_LAMAactive2023-09hl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1078.620Low Dose ICS_LABA_Non Formoterolactive2024-06hl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1078.621Medium ICS_LABA Non Formoterolactive2023-11hl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1078.623LAMA Allergy SCTactive2023-09hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1078.624LABA Allergy SCTactive2023-09hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1078.625BetaBlock NonCS Secondary Allergy SCTactive2023-09hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1078.626Eplerenone Allergy SCTactive2023-09hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1078.627Spironolactone Allergy SCTactive2023-09hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1078.628SGLT2 Inhibitors Allergy SCTactive2024-04hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1078.629PIM_Refill_Request_Antilipemics_LFTsactive2023-09hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1078.630Angiotensin Receptor Neprilysin Inhibitor(ARNI) Allergy SCTactive2023-09hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1078.631Pneumococcal Vaccine Allergy SCTactive2023-09hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1078.632Meglitinides Allergy SCTactive2024-04hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1078.633DPP4i Allergy SCTactive2024-04hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1078.635Alpha_glucosidase inhibitors allergy SCTactive2023-09hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1078.636Glucagon_Like Peptide 1 Receptor Agonist (GLP1RA) Allergy SCTactive2023-09hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1078.637Insulins Allergy SCTactive2023-09hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1078.638TZD Allergy SCTactive2024-04hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1078.639T2DM_Medications Allergy SCTactive2023-09hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1078.642T2DM_Medications Allergy RXNORMactive2023-09hl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1078.643T2DM_Medications Allergy SNOMEDactive2023-09hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1078.646T2DM_Medication Allergy Intoleranceactive2023-09hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1078.647Statins Allergy Intoleranceactive2023-09hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1078.649ACE Inhibitors Allergy Intoleranceactive2025-04hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1078.650ARB Allergy Intoleranceactive2025-04hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1078.652Long Acting Muscarinic Antagonists (LAMA) Allergy Intoleranceactive2023-09hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1078.653Long Acting Beta Agonists (LABA) Allergy Intoleranceactive2023-09hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1078.654BetaBlocker NonCS Secondary Allergy Intoleranceactive2023-09hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1078.656MRA Allergy Intoleranceactive2025-04hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1078.657Eplerenone Allergy Intoleranceactive2023-09hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1078.658Spironolactone Allergy Intoleranceactive2023-09hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1078.659SGLT2i Allergy Intoleranceactive2025-04hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1078.660Angiotensin Receptor Neprilysin Inhibitor(ARNI) Allergy Intoleranceactive2023-09hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1078.661Tetanus, Diphtheria, Pertusis (Tdap) Vaccine Allergy Intoleranceactive2023-09hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1078.665Tetanus toxoid, diphtheria (Td) Vaccine Allergy Intoleranceactive2023-09hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1078.666Human Papillomavirus (HPV) vaccine Allergy Intoleranceactive2023-09hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1078.667Herpes Zoster Vaccine Allergy Intoleranceactive2023-09hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1078.670Pneumococcal Vaccine Allergy Intoleranceactive2023-09hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1078.671Inhaled Corticosteroids(ICS) Allergy Intoleranceactive2023-09hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1078.672LABA(Formoterol only)active2023-11hl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1078.674PIM_Tirzepatideactive2023-09hl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1078.675GLP1RA Allergy Intoleranceactive2025-04hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1078.676PIM_Diabetes_Testing_Suppliesactive2025-05hl7cms
us.nlm.vsacR42.16.840.1.113762.1.4.1078.677PIM_H2_Antagonistsactive2023-09hl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1078.678SGLT2i DM CKDactive2023-10hl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1078.679SGLT2i DM ASCVDactive2023-10hl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1078.683OIA_Gout_Medicationsactive2025-05hl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1078.684GlumetzaSubstitutionactive2023-10hl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1078.685MetforminER500mgactive2023-10hl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1078.686PIM_Metforminactive2023-10hl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1078.687PIM_Glipizideactive2024-10hl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1078.689PIM_Glipizide_Glyburide_Glimepirideactive2024-11hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1078.690PIM_Insulin_Meglitinidesactive2023-10hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1078.691PIM_Glyxambiactive2023-10hl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1078.692PIM_Farxigaactive2023-10hl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1078.693PIM_Invokanaactive2023-10hl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1078.694PIM_Jardianceactive2023-10hl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1078.695PIM_Invokana_Jardianceactive2023-10hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1078.696Reclastactive2023-10hl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1078.697LAMA_LABA Combination 1 Inhaleractive2023-11hl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1078.698PIM_Contraceptivesactive2023-12hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1078.699Selected Oral Antiemetics for Migraineactive2023-11hl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1078.700PIM_DEXA_Scanactive2023-12hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1078.701PIM_DEXA_Scan_CPT_LOINCactive2023-12hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1078.702PIM_SSRIsactive2023-12hl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1078.703PIM_SNRIsactive2023-12hl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1078.704PIM_NRIsactive2024-02hl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1078.705PIM_TCAsactive2023-12hl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1078.706PIM_Citalopramactive2023-12hl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1078.707PIM_Hydroxyzineactive2023-12hl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1078.708PIM_Buspironeactive2023-12hl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1078.709PIM_Bupropionactive2023-11hl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1078.710PIM_Mirtazapineactive2023-11hl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1078.711PIM_Trazodoneactive2023-11hl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1078.712PIM_IHD_CHD_CAD_ICD10active2023-11hl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1078.713PIM_IHD_CHD_CAD_SNOMEDactive2023-11hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1078.714PIM_Gabapentinactive2023-11hl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1078.715PIM_Allergy_Nasal_Spraysactive2023-11hl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1078.716PIM_Allergy_Oral_Medsactive2023-11hl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1078.717PIM_Allergy_Nasal_Oralactive2023-11hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1078.719OCS_Prednisoloneactive2023-11hl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1078.72Inhaled corticosteroids (IC)active2023-11hl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1078.720COPD_Ofloxacinactive2023-11hl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1078.721COPD_Ciprofloxacinactive2023-11hl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1078.722COPD_Doxycyclineactive2023-11hl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1078.723Macrolide Allergy SCTactive2023-11hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1078.724Macrolide Allergy Intoleranceactive2025-04hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1078.725Prednisone Allergy SCTactive2023-11hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1078.727Tetracycline Allergy SCTactive2023-11hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1078.728Tetracycline Allergy Intoleranceactive2023-11hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1078.729Fluoroquinolones Allergy SCTactive2023-11hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1078.730Fluoroquinolone Allergy Intoleranceactive2023-11hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1078.731Penicillin Allergy RXNORMactive2023-11hl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1078.732Penicillin Allergy SCTactive2023-11hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1078.733Penicillin Allergy Intoleranceactive2025-04hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1078.734PIM_Metformin_Single_Ingredient_Onlyactive2023-11hl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1078.735PIM_Metformin_Combo_Ingredient_Onlyactive2023-11hl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1078.737Pneumonia SCTactive2023-12hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1078.738Pneumoniaactive2023-12hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1078.739Pulmonary Embolism I10active2023-12hl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1078.742Pulmonary Embolism SCTactive2023-12hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1078.743Pulmonary Embolismactive2023-12hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1078.744Influenza I10active2023-12hl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1078.745Influenza SCTactive2023-12hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1078.746Influenza (Tests for influenza A or B virus Antigen)active2023-12hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1078.747Influenzaactive2023-12hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1078.748COVID 19 I10active2023-12hl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1078.749COVID19 SCTactive2023-12hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1078.750COVID19active2023-12hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1078.752RSV I10active2023-12hl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1078.753RSV SCTactive2023-12hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1078.754RSVactive2023-12hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1078.755Respiratory Rate SCTactive2023-12hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1078.756Respiratory Rate LOINCactive2024-09hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1078.757Respiratory Rateactive2023-12hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1078.758Acute Respiratory Failure I10active2023-12hl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1078.759Acute Respiratory Failure SCTactive2023-12hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1078.760Acute Respiratory Failureactive2023-12hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1078.761Dyspnea SCTactive2023-12hl7sct